Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks

Antiretroviral therapy initiation has been linked to bone mineral density and bone biomarker changes. We assessed long-term bone turnover biomarker effects over 144 weeks in patients initiating dolutegravir (DTG) + abacavir/lamivudine (ABC/3TC) versus efavirenz/emtricitabine/tenofovir disoproxil fum...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:AIDS
Prif Awduron: Tebas, Pablo, Kumar, Princy, Hicks, Charles, Granier, Catherine, Wynne, Brian, Min, Sherene, Pappa, Keith
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Lippincott Williams & Wilkins 2015
Pynciau:
Clinical Science
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4645955/
https://ncbi.nlm.nih.gov/pubmed/26355674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000863
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg